Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

How many people get sick from foodborne illnesses?

Up to 48 million people get sick from a foodborne illness every year, and up to 3,000 are estimated to die from them.

USAFacts

US officials block Elf Bar-maker from importing 1.4 million illegal e-cigarettes

U.S. officials recently seized more than 1.4 million illegal e-cigarettes from the Chinese manufacturer behind Elf Bar

The Independent UK

US Supreme Court ruling on abortion pill could 'tie the hands of every state'

The US Supreme Court is set to decide the fate of a pill essential for medical abortions. Access to mifepristone, once called the “pill of Cain” by the Vatican, may be heavily restricted across all states if the highest court upholds a lower-court ruling limiting access to the drug. Expert…

France 24

From analysis to the latest developments in health,
read the most diverse news in one place.

When authoritative sources hold onto bad data: A legal scholar explains the need for government databases to retract information

In 2004, Hwang Woo-suk was celebrated for his breakthrough discovery creating cloned human embryos, and his work was published in the prestigious journal Science. But the discovery was too good to be true; Dr. Hwang had fabricated the data. Science publicly retracted the article and assembled a team to investigate…

The Conversation

CRISPR and other new technologies open doors for drug development, but which diseases get prioritized? It comes down to money and science

Prescription drugs and vaccines revolutionized health care, dramatically decreasing death from disease and improving quality of life across the globe. But how do researchers, universities and hospitals, and the pharmaceutical industry decide which diseases to pursue developing drugs for?

The Conversation

Our World Isn’t A Total Nightmare And These 39 Things Prove That, As Shared Online

It might seem that every time we check the news or simply go on social media, we keep getting bad news about the world. And that makes us think that at this rate, the world will end very soon.

Bored Panda

What's at Stake in the Supreme Court's Abortion Pill Case

The Court announced today that it would take up a case involving access to the abortion-inducing drug mifepristone.

Reason

Read news from The Economist, FT, and more,
with one subscription

Analysts Expect This Russell 2000 Penny Stock to Double

This small-cap penny stock is trading at a massive discount to consensus price target estimates, and company insiders have been scooping up the shares.

Barchart

Zelensky Meets Nordic Leaders, FDA Reviews MDMA, Kid Rock Resolves Beef

Ukrainian President Zelensky visits Oslo following Washington trip; MDMA could be PTSD treatment option; Kid Rock ends Bud Light boycott.

Top News

FDA Seeks Power for Eyedrops Recalls Amid Foreign Inspections Woes

U.S. health officials grapple with inadequate inspection of overseas eyedrop factories, leading to recalls of potentially dangerous products.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Safer eyedrops will require new FDA powers and resources, experts say

Repeated recalls of eyedrops are drawing new attention to the limited powers U.S. regulators have to oversee medical products made overseas

Roll Call

Supreme Court to hear abortion pill case - Roll Call

The case is the first major Supreme Court abortion case since the landmark Dobbs v. Jackson Women’s Health Organization decision last year.

Investors Business Daily

Here's What The FDA Approval Of Gene Editing For Sickle Cell Means For CRSP Stock And The Future Of Medicine

Biotech stocks could be at a major turning point after FDA approval of the first gene editing drug using Crispr technology. But gene editing therapies aren’t without risk, and questions remain about the safety and cost effectiveness of these experimental treatments.

StockNews.com

3 Solid Pharma Stocks for a Healthy Year-End Portfolio

The pharma industry is transforming due to the rapid adoption of AI and global healthcare spending, fostering innovation and patient care advancements. Therefore, fundamentally sound pharma stocks Eli Lilly (LLY), Wave Life Sciences (WVE) and Johnson & Johnson (JNJ) might be worth adding to boost your portfolio. Continue reading.

The Street

Cathie Wood sinks $11 million into Crispr following landmark U.S. approval

The stock slumped hard in the past week.

StockNews.com

3 Pharma Powerhouses to Boost Your Year-End Investments

Backed by an ever-growing need for chronic disease treatments, rapid investments in research and development, and widespread integration of technology, the pharmaceutical sector is anticipated to flourish. Thus, as we approach the end of 2023, three solid pharma stocks, GoodRx Holdings (GDRX), CytomX Therapeutics (CTMX), and Neurocrine Biosciences (NBIX), could…

WEKU

Up First briefing: Trump won't testify; FDA approves landmark gene-editing treatment

Donald Trump plans to skip testifying for a second time in the New York civil fraud trial. The FDA has approved the first-ever gene-editing treatment for a human disease.

1 … 45 46 47 48

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals

167 stories

the Fifth Circuit

146 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.